The gut microbiota influences anticancer immunosurveillance and general health (original) (raw)

• Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J. & Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991–998 (2002).
  Article PubMed CAS Google Scholar
• Dunn, G. P., Old, L. J. & Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137–148 (2004).
  Article PubMed CAS Google Scholar
• Frederick, D. T. et al. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin. Cancer Res. 19, 1225–1231 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Galluzzi, L., Buque, A., Kepp, O., Zitvogel, L. & Kroemer, G. Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell 28, 690–714 (2015).
  Article PubMed CAS Google Scholar
• Zitvogel, L., Apetoh, L., Ghiringhelli, F. & Kroemer, G. Immunological aspects of cancer chemotherapy. Nat. Rev. Immunol. 8, 59–73 (2008).
  Article PubMed CAS Google Scholar
• Fridman, W. H., Zitvogel, L., Sautes-Fridman, C. & Kroemer, G. The immune contexture in cancer prognosis and treatment. Nat. Rev. Clin. Oncol. 14, 717–734 (2017).
  Article PubMed CAS Google Scholar
• Szczepaniak Sloane, R. A. et al. Interaction of molecular alterations with immune response in melanoma. Cancer 123, 2130–2142 (2017).
  Article PubMed Google Scholar
• Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56–61 (2015).
  Article PubMed CAS Google Scholar
• Sharma, P. & Allison, J. P. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161, 205–214 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711–723 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Ribas, A. et al. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. Lancet Oncol. 16, 908–918 (2015).
  Article PubMed CAS PubMed Central Google Scholar
• Prieto, P. A. et al. CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma. Clin. Cancer Res. 18, 2039–2047 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Krummel, M. F. & Allison, J. P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459–465 (1995).
  Article PubMed CAS Google Scholar
• Leach, D. R., Krummel, M. F. & Allison, J. P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734–1736 (1996).
  Article PubMed CAS Google Scholar
• Gros, A. et al. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors. J. Clin. Invest. 124, 2246–2259 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Topalian, S. L. et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443–2454 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Brahmer, J. R. et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366, 2455–2465 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Robert, C. et al. Pembrolizumab versus ipilimumab in advanced melanoma. N. Engl. J. Med. 372, 2521–2532 (2015).
  Article PubMed CAS Google Scholar
• Hamid, O. et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N. Engl. J. Med. 369, 134–144 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Larkin, J., Hodi, F. S. & Wolchok, J. D. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N. Engl. J. Med. 373, 1270–1271 (2015).
  Article PubMed CAS Google Scholar
• Postow, M. A. et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N. Engl. J. Med. 372, 2006–2017 (2015).
  Article PubMed PubMed Central Google Scholar
• Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91–97 (2018).
  Article PubMed CAS Google Scholar
• Kaderbhai, C. et al. Antibiotic use does not appear to influence response to nivolumab. Anticancer Res. 37, 3195–3200 (2017).
  PubMed Google Scholar
• Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer–immune set point. Nature 541, 321–330 (2017).
  Article PubMed CAS Google Scholar
• Viaud, S. et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971–976 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Iida, N. et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342, 967–970 (2013).
  Article PubMed CAS PubMed Central Google Scholar
• Daillere, R. et al. Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity 45, 931–943 (2016).
  Article PubMed CAS Google Scholar
• Peled, J. U. et al. Intestinal microbiota and relapse after hematopoietic-cell transplantation. J. Clin. Oncol. 35, 1650–1659 (2017).
  Article PubMed PubMed Central Google Scholar
• Vetizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079–1084 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Sivan, A. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084–1089 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Bhatt, A. P., Redinbo, M. R. & Bultman, S. J. The role of the microbiome in cancer development and therapy. CA Cancer J. Clin. 67, 326–344 (2017).
  Article PubMed PubMed Central Google Scholar
• Berry, D. et al. Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing. Proc. Natl Acad. Sci. USA 110, 4720–4725 (2013).
  Article PubMed PubMed Central Google Scholar
• Derrien, M., Vaughan, E. E., Plugge, C. M. & de Vos, W. M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54, 1469–1476 (2004).
  Article PubMed CAS Google Scholar
• Ottman, N. et al. Genome-scale model and omics analysis of metabolic capacities of Akkermansia muciniphila reveal a preferential mucin-degrading lifestyle. Appl. Environ. Microbiol. 83, e01014–17 (2017).
  Article PubMed PubMed Central CAS Google Scholar
• Ouwerkerk, J. P. et al. Adaptation of Akkermansia muciniphila to the oxic-anoxic interface of the mucus layer. Appl. Environ. Microbiol. 82, 6983–6993 (2016).
  Article PubMed Central CAS PubMed Google Scholar
• Collado, M. C., Derrien, M., Isolauri, E., de Vos, W. M. & Salminen, S. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 73, 7767–7770 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• van Passel, M. W. J. et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLOS ONE 6, e16876 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Derrien, M., Belzer, C. & de Vos, W. M. Akkermansia muciniphila and its role in regulating host functions. Microb. Pathog. 106, 171–181 (2017).
  Article PubMed Google Scholar
• Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546 (2013).
  Article PubMed CAS Google Scholar
• Dao, M. C. et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65, 426–436 (2016).
  Article PubMed CAS Google Scholar
• Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Matson, V. et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359, 104–108 (2018).
  Article PubMed CAS PubMed Central Google Scholar
• Schug, Z. T. et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27, 57–71 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Levin, V. A. & Levin, E. M. Dissolution and stability of carmustine in the absence of ethanol. Sel. Cancer Ther. 5, 33–35 (1989).
  Article PubMed CAS Google Scholar
• Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559–563 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Brand, A. et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24, 657–671 (2016).
  Article PubMed CAS Google Scholar
• de Vos, W. M. Microbe profile: Akkermansia muciniphila: a conserved intestinal symbiont that acts as the gatekeeper of our mucosa. Microbiology 163, 646–648 (2017).
  Article PubMed CAS Google Scholar
• Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066–9071 (2013).
  Article PubMed PubMed Central Google Scholar
• Plovier, H. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23, 107–113 (2016).
  Article PubMed CAS Google Scholar
• Lee, H. & Ko, G. Effect of metformin on metabolic improvement and gut microbiota. Appl. Environ. Microbiol. 80, 5935–5943 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262–266 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Bauer, P. V. et al. Metformin alters upper small intestinal microbiota that impact a glucose-SGLT1-sensing glucoregulatory pathway. Cell Metab. 27, 101–117 (2018).
  Article PubMed CAS Google Scholar
• Campbell, J. M., Bellman, S. M., Stephenson, M. D. & Lisy, K. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis. Ageing Res. Rev. 40, 31–44 (2017).
  Article PubMed CAS Google Scholar
• Ganesh, B. P., Klopfleisch, R., Loh, G. & Blaut, M. Commensal Akkermansia muciniphila exacerbates gut inflammation in _Salmonella typhimurium_-infected gnotobiotic mice. PLoS ONE 8, e74963 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Hakansson, A. et al. Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice. Clin. Exp. Med. 15, 107–120 (2015).
  Article PubMed CAS Google Scholar
• Kang, C. S. et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS ONE 8, e76520 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Zackular, J. P. et al. The gut microbiome modulates colon tumorigenesis. mBio 4, e00692–13 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Dingemanse, C. et al. Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. Carcinogenesis 36, 1388–1396 (2015).
  Article PubMed CAS Google Scholar
• Seregin, S. S. et al. NLRP6 function in inflammatory monocytes reduces susceptibility to chemically induced intestinal injury. Mucosal Immunol. 10, 434–445 (2017).
  Article PubMed CAS Google Scholar
• Zella, G. C. et al. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm. Bowel Dis. 17, 1092–1100 (2011).
  Article PubMed Google Scholar
• Shono, Y. et al. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci. Transl Med. 8, 339ra71 (2016).
  Article PubMed PubMed Central CAS Google Scholar
• Gill, T., Asquith, M., Rosenbaum, J. T. & Colbert, R. A. The intestinal microbiome in spondyloarthritis. Curr. Opin. Rheumatol. 27, 319–325 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Hold, G. L., Schwiertz, A., Aminov, R. I., Blaut, M. & Flint, H. J. Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl. Environ. Microbiol. 69, 4320–4324 (2003).
  Article PubMed PubMed Central CAS Google Scholar
• Martín, R. et al. Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: a step forward in the use of F. prausnitzii as a next-generation probiotic. Front. Microbiol. 8, 1226 (2017).
  Article PubMed PubMed Central Google Scholar
• Lay, C. et al. Design and validation of 16S rRNA probes to enumerate members of the Clostridium leptum subgroup in human faecal microbiota. Environ. Microbiol. 7, 933–946 (2005).
  Article PubMed CAS Google Scholar
• Duncan, S. H., Hold, G. L., Harmsen, H. J., Stewart, C. S. & Flint, H. J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol. 52, 2141–2146 (2002).
  PubMed CAS Google Scholar
• Scheppach, W. Effects of short chain fatty acids on gut morphology and function. Gut 35, S35–S38 (1994).
  Article PubMed PubMed Central CAS Google Scholar
• Wrzosek, L. et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 11, 61 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Sokol, H. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 15, 1183–1189 (2009).
  Article PubMed CAS Google Scholar
• Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731–16736 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Rajilic–Stojanovic, M. et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792–1801 (2011).
  Article PubMed CAS Google Scholar
• Turnbaugh, P. J., Baeckhed, F., Fulton, L. & Gordon, J. I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213–223 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Graessler, J. et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. Pharmacogenom. J. 13, 514–522 (2013).
  Article CAS Google Scholar
• Balamurugan, R. et al. Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br. J. Nutr. 103, 335–338 (2010).
  Article PubMed CAS Google Scholar
• Zhang, X. et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLOS ONE 8, e71108 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99–103 (2013).
  Article PubMed CAS Google Scholar
• De Palma, G. et al. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 10, 63 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• De Palma, G., Nadal, I., Collado, M. C. & Sanz, Y. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br. J. Nutr. 102, 1154–1160 (2009).
  Article PubMed CAS Google Scholar
• Biagi, E. et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLOS ONE 5, e10667 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Leclercq, S. et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl Acad. Sci. USA 111, E4485–E4493 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Morgan, X. C. & Huttenhower, C. Human microbiome analysis. PLoS Comput. Biol. 8, e1002808 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97–103 (2018).
  Article PubMed CAS Google Scholar
• Frankel, A. E. et al. Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients. Neoplasia 19, 848–855 (2017).
  Article PubMed PubMed Central CAS Google Scholar
• Chaput, N. et al. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann. Oncol. 28, 1368–1379 (2017).
  Article PubMed CAS Google Scholar
• Hidalgo-Cantabrana, C. et al. Bifidobacteria and their health-promoting effects. Microbiol. Spectr. https://doi.org/10.1128/microbiolspec.BAD-0010-2016 (2018).
• Felis, G. E. & Dellaglio, F. Taxonomy of Lactobacill i and Bifidobacteria. Curr. Issues Intest. Microbiol. 8, 44–61 (2007).
  PubMed CAS Google Scholar
• Picard, C. et al. Review article: Bifidobacteria as probiotic agents — physiological effects and clinical benefits. Aliment. Pharmacol. Ther. 22, 495–512 (2005).
  Article PubMed CAS Google Scholar
• Russell, D. A., Ross, R. P., Fitzgerald, G. F. & Stanton, C. Metabolic activities and probiotic potential of Bifidobacteria. Int. J. Food Microbiol. 149, 88–105 (2011).
  Article PubMed CAS Google Scholar
• Delcenserie, V. et al. Description of a new species. Bifidobacterium crudilactis sp. nov., isolated from raw milk and raw milk cheeses. Syst. Appl. Microbiol. 30, 381–389 (2007).
  Article PubMed CAS Google Scholar
• Verhelst, R. et al. Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol. 5, 61 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Okamoto, M., Benno, Y., Leung, K. P. & Maeda, N. Bifidobacterium tsurumiense sp. nov., from hamster dental plaque. Int. J. Syst. Evol. Microbiol. 58, 144–148 (2008).
  Article PubMed CAS Google Scholar
• Arboleya, S., Solis, G., Fernandez, N., de los Reyes-Gavilan, C. G. & Gueimonde, M. Facultative to strict anaerobes ratio in the preterm infant microbiota: a target for intervention? Gut Microbes 3, 583–588 (2012).
  Article PubMed PubMed Central Google Scholar
• Schell, M. A. et al. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc. Natl Acad. Sci. USA 99, 14422–14427 (2002).
  Article PubMed PubMed Central CAS Google Scholar
• Lugli, G. A. et al. Investigation of the evolutionary development of the genus Bifidobacterium by comparative genomics. Appl. Environ. Microbiol. 80, 6383–6394 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Milani, C. et al. Genomic encyclopedia of type strains of the genus Bifidobacterium. Appl. Environ. Microbiol. 80, 6290–6302 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Fernandez, L. et al. The microbiota of human milk in healthy women. Cell. Mol. Biol. 59, 31–42 (2013).
  PubMed CAS Google Scholar
• Martín, R. et al. Isolation of Bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl. Environ. Microbiol. 75, 965–969 (2009).
  Article PubMed CAS Google Scholar
• Sonnenburg, J. L., Chen, C. T. & Gordon, J. I. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol. 4, e413 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Rios-Covian, D. et al. Different metabolic features of Bacteroides fragilis growing in the presence of glucose and exopolysaccharides of bifidobacteria. Front. Microbiol. 6, 825 (2015).
  Article PubMed PubMed Central Google Scholar
• Rios-Covian, D., Gueimonde, M., Duncan, S. H., Flint, H. J. & de los Reyes-Gavilan, C. G. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol. Lett. 362, fnv176 (2015).
  Article PubMed CAS Google Scholar
• Milani, C. et al. Bifidobacteria exhibit social behavior through carbohydrate resource sharing in the gut. Sci. Rep. 5, 15782 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Egan, M. et al. Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium. BMC Microbiol. 14, 282 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Lopez, P. et al. Treg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy. Vaccine 30, 825–829 (2012).
  Article PubMed CAS Google Scholar
• Griffiths, E. A. et al. In vivo effects of Bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in BALB/C mice. Dig. Dis. Sci. 49, 579–589 (2004).
  Article PubMed CAS Google Scholar
• Wang, Z. et al. The relationship between intestinal Bifidobacteria and bacteria/endotoxin translocation in scalded rats [Chinese]. Zhonghua Shao Shang Za Zhi 18, 365–368 (2002).
  PubMed CAS Google Scholar
• Wang, Z. et al. The role of Bifidobacteria in gut barrier function after thermal injury in rats. J. Trauma 61, 650–657 (2006).
  Article PubMed Google Scholar
• Furrie, E. et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54, 242–249 (2005).
  Article PubMed PubMed Central CAS Google Scholar
• Billimoria, Z. C., Pandya, S., Bhatt, P. & Pandya, B. Probiotics — to use, or not to use? An updated meta-analysis. Clin. Pediatr. 55, 1242–1244 (2016).
  Article Google Scholar
• Costeloe, K., Hardy, P., Juszczak, E., Wilks, M. & Millar, M. R. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 387, 649–660 (2016).
  Article PubMed Google Scholar
• Yin, Y. N., Yu, Q. F., Fu, N., Liu, X. W. & Lu, F. G. Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J. Gastroenterol. 16, 3394–3401 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• [No authors listed.] Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 6: suitability of taxonomic units notified to EFSA until March 2017. EFSA J. 15, 4884 (2017).
  Google Scholar
• Didari, T., Solki, S., Mozaffari, S., Nikfar, S. & Abdollahi, M. A systematic review of the safety of probiotics. Exp. Opin. Drug Saf. 13, 227–239 (2014).
  Article Google Scholar
• Selinger, C. P. et al. Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. J. Hosp. Infect. 84, 159–165 (2013).
  Article PubMed CAS Google Scholar
• Yu, J. et al. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway. Int. J. Cancer 139, 1318–1326 (2016).
  Article PubMed CAS Google Scholar
• Raisch, J., Rolhion, N., Dubois, A., Darfeuille-Michaud, A. & Bringer, M. A. Intracellular colon cancer-associated Escherichia coli promote protumoral activities of human macrophages by inducing sustained COX-2 expression. Lab. Invest. 95, 296–307 (2015).
  Article PubMed CAS Google Scholar
• Sobhani, I. et al. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Ther. Adv. Gastroenterol. 6, 215–229 (2013).
  Article CAS Google Scholar
• Zhu, Q., Gao, R., Wu, W. & Qin, H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumor Biol. 34, 1285–1300 (2013).
  Article Google Scholar
• Ohigashi, S. et al. Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig. Dis. Sci. 58, 1717–1726 (2013).
  Article PubMed CAS Google Scholar
• Le Leu, R. K., Hu, Y., Brown, I. L., Woodman, R. J. & Young, G. P. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 31, 246–251 (2010).
  Article PubMed CAS Google Scholar
• Roller, M., Clune, Y., Collins, K., Rechkemmer, G. & Watzl, B. Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br. J. Nutr. 97, 676–684 (2007).
  Article PubMed CAS Google Scholar
• Worthley, D. L. et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am. J. Clin. Nutr. 90, 578–586 (2009).
  Article PubMed CAS Google Scholar
• Rafter, J. et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 85, 488–496 (2007).
  Article PubMed CAS Google Scholar
• Liu, Z. et al. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial. BMC Gastroenterol. 15, 34 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Liu, Z.-H. et al. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial. Am. J. Clin. Nutr. 97, 117–126 (2013).
  Article PubMed CAS Google Scholar
• Wada, M. et al. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support. Care Cancer 18, 751–759 (2010).
  Article PubMed Google Scholar
• Xiao, J. Z. et al. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin. Exp. Allergy 36, 1425–1435 (2006).
  Article PubMed CAS Google Scholar
• Malaguarnera, M. et al. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig. Dis. Sci. 52, 3259–3265 (2007).
  Article PubMed Google Scholar
• Namba, K., Hatano, M., Yaeshima, T., Takase, M. & Suzuki, K. Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly. Biosci. Biotechnol. Biochem. 74, 939–945 (2010).
  Article PubMed CAS Google Scholar
• Tamaki, H. et al. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: a randomized, double-blinded, placebo-controlled multicenter trial. Dig. Endosc. 28, 67–74 (2016).
  Article PubMed Google Scholar
• Rong, Y. et al. Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8+ T cell response and better prognosis in HBV-related hepatocellular carcinoma. Exp. Cell Res. 358, 352–359 (2017).
  Article PubMed CAS Google Scholar
• Li, X. et al. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther. 10, 105 (2003).
  Article PubMed CAS Google Scholar
• Kuwahara, T. et al. Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation. Proc. Natl Acad. Sci. USA 101, 14919–14924 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Geva-Zatorsky, N. et al. In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria. Nat. Med. 21, 1091–1100 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Mazmanian, S. K., Round, J. L. & Kasper, D. L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620–625 (2008).
  Article PubMed CAS Google Scholar
• Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. & Kasper, D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107–118 (2005).
  Article PubMed CAS Google Scholar
• Telesford, K. M. et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39+ Foxp3+ T cells and Treg function. Gut Microbes 6, 234–242 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Chu, H. et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science 352, 1116–1120 (2016).
  Article PubMed PubMed Central CAS Google Scholar
• Dubin, K. et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat. Commun. 7, 10391 (2016).
  Article PubMed PubMed Central CAS Google Scholar
• Rabizadeh, S. et al. Enterotoxigenic Bacteroides fragilis: a potential instigator of colitis. Inflamm. Bowel Dis. 13, 1475–1483 (2007).
  Article PubMed Google Scholar
• Kanauchi, O. et al. Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity. World J. Gastroenterol. 12, 1071–1077 (2006).
  Article PubMed PubMed Central Google Scholar
• Gordon, S. et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J. Clin. Microbiol. 30, 2373–2378 (1992).
  PubMed PubMed Central CAS Google Scholar
• Lister, D. M. et al. Outbreak of vanB vancomycin-resistant Enterococcus faecium colonization in a neonatal service. Am. J. Infect. Control 43, 1061–1065 (2015).
  Article PubMed Google Scholar
• Freitas, A. R. et al. Multilevel population genetic analysis of vanA and vanB Enterococcus faecium causing nosocomial outbreaks in 27 countries (1986–2012). J. Antimicrob. Chemother. 71, 3351–3366 (2016).
  Article PubMed CAS Google Scholar
• Alatorre-Fernandez, P. et al. A polyclonal outbreak of bloodstream infections by Enterococcus faecium in patients with hematologic malignancies. Am. J. Infect. Control 45, 260–266 (2017).
  Article PubMed Google Scholar
• Porter, L. A. & Goldberg, J. B. Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis. Front. Cell. Infect. Microbiol. 1, 9 (2011).
  Article PubMed PubMed Central Google Scholar
• Pitt, J. M. et al. Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota. Oncoimmunology 6, e1132137 (2017).
  Article PubMed CAS Google Scholar
• Balachandran, V. P. et al. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature 551, 512–516 (2017).
  PubMed CAS PubMed Central Google Scholar
• Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814–821 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Li, J. et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834–841 (2014).
  Article PubMed CAS Google Scholar
• Lloyd-Price, J. et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature 550, 61–66 (2017).
  PubMed PubMed Central CAS Google Scholar
• Costea, P. I. et al. Towards standards for human fecal sample processing in metagenomic studies. Nat. Biotechnol. 35, 1069–1076 (2017).
  PubMed CAS Google Scholar
• Song, H. J. & Shim, K. N. Current status and future perspectives of capsule endoscopy. Intest. Res. 14, 21–29 (2016).
  Article PubMed PubMed Central Google Scholar
• Laffin, M. & Madsen, K. L. Fecal microbial transplantation in inflammatory bowel disease: a movement too big to be ignored. Clin. Pharmacol. Ther. 102, 588–590 (2017).
  Article PubMed CAS Google Scholar
• Zitvogel, L., Ayyoub, M., Routy, B. & Kroemer, G. Microbiome and anticancer immunosurveillance. Cell 165, 276–287 (2016).
  Article PubMed CAS Google Scholar
• Foster, K. R., Schluter, J., Coyte, K. Z. & Rakoff-Nahoum, S. The evolution of the host microbiome as an ecosystem on a leash. Nature 548, 43–51 (2017).
  Article PubMed PubMed Central CAS Google Scholar
• Ishikawa, D. et al. Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis. Inflamm. Bowel Dis. 23, 116–125 (2017).
  Article PubMed Google Scholar
• Klaenhammer, T. R., Kleerebezem, M., Kopp, M. V. & Rescigno, M. The impact of probiotics and prebiotics on the immune system. Nat. Rev. Immunol. 12, 728–734 (2012).
  Article PubMed CAS Google Scholar
• Sonnenburg, J. L. & Backhed, F. Diet-microbiota interactions as moderators of human metabolism. Nature 535, 56–64 (2016).
  Article PubMed CAS PubMed Central Google Scholar
• Pflug, N. et al. Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. Oncoimmunology 5, e1150399 (2016).
  Article PubMed PubMed Central CAS Google Scholar
• Galloway-Pena, J. R. et al. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer 122, 2186–2196 (2016).
  Article PubMed CAS Google Scholar
• Mima, K. et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 65, 1973–1980 (2016).
  Article PubMed CAS Google Scholar
• Yu, T. et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170, 548–563 (2017).
  Article PubMed PubMed Central CAS Google Scholar
• Routy, B. et al. The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation. Oncoimmunology 6, e1258506 (2017).
  Article PubMed CAS Google Scholar
• Jenq, R. R. et al. Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biol. Blood Marrow Transplant. 21, 1373–1383 (2015).
  Article PubMed PubMed Central Google Scholar
• Geller, L. T. et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357, 1156–1160 (2017).
  Article PubMed PubMed Central CAS Google Scholar
• Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443–1448 (2017).
  Article PubMed CAS PubMed Central Google Scholar